ROS1 GENE MUTATION
Clinical trials for ROS1 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ROS1 GENE MUTATION trials appear
Sign up with your email to follow new studies for ROS1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Guided drugs aim to shrink brain tumors
Disease control OngoingThis phase 2 trial tests whether genetic testing can help doctors pick the right targeted drug for people whose solid tumors have spread to the brain. About 50 participants with specific gene mutations (like NTRK, ROS1, CDK, PI3K, or KRAS G12C) will receive one of four drugs: abe…
Matched conditions: ROS1 GENE MUTATION
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Smartwatch and app aim to track lung cancer symptoms in real time
Knowledge-focused OngoingThis study tests whether a remote monitoring system—including a smartphone app, a Fitbit, and a smart pill cap—can effectively track symptoms and side effects in 30 lung cancer patients taking oral targeted therapy. Participants will use the system for up to 24 weeks, and the goa…
Matched conditions: ROS1 GENE MUTATION
Phase: NA • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC